Two-drug combo shown to significantly shrink breast cancer in days
March 10, 2016Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb
Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …
Teva issues US recall of amikacin sulfate injection due to glass identified in vials
March 10, 2016Manufacturing and Production Teva, amikacin sulfate, glass, recall
Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP vials due to the potential …
New manufacturing boss for MSD
March 10, 2016Manufacturing and Production, Medical Communications MSD, manufacturing
MSD has appointed Sanat Chattopadhyay president of the Merck Manufacturing Division (MMD) and an executive vice president of the company. …
Researcher develops strategy to identify antimicrobial drugs that tackle drug-resistant pathogens
March 10, 2016Manufacturing and Production, Research and Development anitmicrobial, drug discovery, drug repurposing, mohamed seleem, purdue university
A researcher from Purdue University’s College of Veterinary Medicine has developed a novel method of repurposing drugs to act as …
Amarin wins case against FDA to promote Vascepa for off-label uses
March 10, 2016Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa
Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …
Lupin completes acquisition of US-based Gavis Pharmaceuticals
March 10, 2016Research and Development, Sales and Marketing FDA, Gavis, Lupin, acquisition, generics
Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …
Survey reveals patient groups’ views on pharma industry
March 10, 2016Research and Development, Sales and Marketing patientview
A new report, published by research and consultancy group PatientView, has revealed the attitude of more than 1,000 patient groups …
Seven quick facts about meldonium – and why it will get Sharapova banned
March 10, 2016Medical Communications, Research and Development 7 things, anti-doping, banned, maria sharapova, medlonum, reasons, susbtance
It’s made world headlines this week, but the drug meldonium would have been unknown to many before it emerged that …
Engineers create lab-grown heart and liver tissue for drug testing and discovery
March 10, 2016Manufacturing and Production, Research and Development 3D, angiochip, artificial heart, drug delivery, innovation, liver, vessels
Researchers at University of Toronto have developed “person-on-a-chip” technology which sees the growing of realistic human tissues outside the body. …
Genmab Darzalex success triggers second milestone payment
March 10, 2016Research and Development, Sales and Marketing Genmab, Janssen, daratumumab, darzalex, follicular lymphoma
Genmab says it has reached a $5 million milestone in its daratumumab collaboration with Janssen as a result of success …
Valeant ends controversial litigation with R&O Pharmacy
March 10, 2016Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal
Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …
Tackling Chronic Kidney Disease – early action will aid prevention this World Kidney Day 2016
March 10, 2016Medical Communications, Research and Development
Today (10th March) marks World Kidney Day 2016. Now in its 11th year, it is the largest such event focused …
Sanofi appoints Novartis executive Dr Ameet Nathwani executive VP and CMO
March 10, 2016Medical Communications
Sanofi has announced the appointment of Dr Ameet Nathwani as a new member of its Executive Committee, and to the …
Rigel names Anne-Marie Duliege chief medical officer
March 9, 2016Medical Communications
Biotech firm Rigel Pharmaceuticals (Nasdaq: RIGL) named Anne-Marie Duliege its chief medical officer, replacing Elliott Grossbard, who is retiring.Dr Grossbard will remain …
Shire launches long-acting ADHD drug in UK
March 9, 2016Sales and Marketing ADHD, Shire
Shire has launched its long-acting ADHD drug Intuniv (guanfacine) in the UK, for children and adolescents aged 6-17. The treatment …
Pfizer enters $5 billion share buyback deal with Goldman Sachs
March 9, 2016Business Services, Research and Development Pfizer, Share buyback, Stock, markets
US drug major Pfizer (NYSE: PFE) on Wednesday said it has entered into an accelerated share repurchase agreement with Goldman, …
Pharma industry’s contribution to NHS medicines bill tops £1 billion
March 9, 2016Manufacturing and Production, Medical Communications, Research and Development ABPI, PPRS, goodwill, pharma industry
The pharmaceutical industry has now contributed over £1 billion to the Department of Health towards the cost of new medicines …
Late-stage Pfizer drug study shows significant reduction in haemophilia B bleeding
March 9, 2016Research and Development BeneFIX, Pfizer, haemophilia B
Pfizer on Wednesday said late-stage trials for its drug candidate to treat haemophilia B showed prophylactic use resulted in significant reduction …
TiGenix says additional data for stem cell product affirms safety profile
March 9, 2016Research and Development Crohn’s disease, TiGenix, crohn's disease, drug trial
Belgian biotech firm TiGenix said the results of a 52-week follow-up study of its trial drug for a stem-cell condition …
Merck chief executive Karl-Ludwig Kley to step down in April
March 9, 2016Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley
It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEO
Tridem begins phase Ib trial of Parkinson’s disease vaccine
